香港股市 已收市

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
1.7500+0.0600 (+3.55%)
市場開市。 截至 11:22AM EDT。

Trinity Biotech plc

IDA Business Park
Bray A98 H5C8
Ireland
353 1 276 9800
https://www.trinitybiotech.com

版塊Healthcare
行業Diagnostics & Research
全職員工

高階主管

名稱頭銜支付行使價出生年份
Mr. John GillardPresident, CEO, Company Secretary & Director863k1981
Mr. Ronan O'CaoimhFounder & Director340k1956
Dr. James Walsh Ph.D.Executive Director of Business Development & Executive Director20k1958
Mr. Des FitzgeraldInterim Chief Financial Officer
Mr. Simon DunneChief Accounting Officer1974
Dr. Gary Keating Ph.D.Chief Technology Officer1973
Ms. Eibhlin KellyChief Information Officer1984
Mr. Colm MolloyGroup Director of Human Resources & Culture1971
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

公司管治

截至 無 止,Trinity Biotech plc 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。